Cargando…
Neovascular age-related macular degeneration in which exudation predominantly occurs as a subretinal fluid during anti-vascular endothelial growth factor treatment
We investigated the characteristics of neovascular age-related macular degeneration (AMD) in which exudation predominantly occurs as a subretinal fluid (SRF) during anti-vascular endothelial growth factor (VEGF) treatment. A total of 509 treatment-naïve neovascular AMD patients treated with anti-VEG...
Autores principales: | Cho, Han Joo, Song, Mi Yeon, Yoon, Wontae, Yoon, Jihyun, Na, Seung Kwan, Lee, Jihyun, Kim, Jaemin, Kim, Jong Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873256/ https://www.ncbi.nlm.nih.gov/pubmed/35210516 http://dx.doi.org/10.1038/s41598-022-07108-4 |
Ejemplares similares
-
Neovascular age-related macular degeneration without exudative recurrence over 24 months after initial remission
por: Cho, Han Joo, et al.
Publicado: (2022) -
Impact of macular fluid features on outcomes of anti-vascular endothelial growth factor treatment for type 3 macular neovascularization
por: Yoon, Wontae, et al.
Publicado: (2021) -
The Effect of Topical Bromfenac on Intraretinal and Subretinal Fluid in Neovascular Age-Related Macular Degeneration
por: Abdolrahimzadeh, Solmaz, et al.
Publicado: (2020) -
Tolerating subretinal fluid in the treatment of neovascular age-related macular degeneration with intravitreal aflibercept
por: Yildiz, Dilan, et al.
Publicado: (2021) -
Intraretinal and subretinal fluid in exudative nonproliferative macular telangiectasia type 2
por: Manayath, George J., et al.
Publicado: (2022)